je.st
news
IBB Has A Formidable Challenger In BBP
2015-05-30 10:41:58| Biotech - Topix.net
A pure biotech ETF, BBP has entered the investment sphere that focuses on the biotechnology cohort with at least one FDA approved product. BBP is a pure biotech play with no holdings in the generic or specialty pharma, life science tools, medical device/diagnostic, or other healthcare companies.
Tags: in
formidable
challenger
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||